Fwd: Proposal for Strategic Business Collaboration.

---------- Forwarded message ----------
From: Dr. Shingo Iwamoto <fachur.rochman@sigma.co.id>
Date: Thursday, August 7, 2025
Subject: Proposal for Strategic Business Collaboration.
To: Recipients <fachur.rochman@sigma.co.id>

Dear Esteemed Professional,

I hope this message finds you well.

Nichi-Iko Pharmaceutical Co., Ltd., a leading pharmaceutical manufacturer based in Japan, is currently seeking a qualified individual to serve as our official representative in South Africa. This role involves managing mineral procurement and overseeing the establishment of our annex office in South Africa under a five-year contractual agreement.

This is a strategic opportunity to represent a respected global brand and play a key role in expanding our international presence. We are offering a competitive compensation package along with decision-making autonomy.

If you are interested in learning more, kindly respond to this message for further details.

Warm regards,
Dr. Shingo Iwamoto
President & CEO
Nichi-Iko Pharmaceutical Co., Ltd.
5-4 Nihonbashi-Honcho 1-chome, Chuo-ku, Tokyo, Japan
Website: https://www.nichiiko.co.jp/

------

Important: Confidential, Personal Data & Compliance
This email is confidential, may contain personal data/legally privileged information. Intended solely for the recipient. Telkomsigma adheres to business ethics, PDP compliance (Law No. 27/2022), and information security standards (ISO 27001). If received in error, please notify sender immediately and delete this email. Unauthorized use may have legal consequences. Views expressed are solely the sender's, not necessarily Telkomsigma's official stance. We are not liable for any loss from viruses/malware, despite precautions.
Telkomsigma Graha Telkomsigma II Jl. CBD lot VIII Nomor 8, Tangerang Selatan 15321, Indonesia
www.telkomsigma.co.id